Basilea Pharmaceutica AG
SIX:BSLN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Basilea Pharmaceutica AG
SIX:BSLN
|
CH |
Wall St Price Targets
BSLN Price Targets Summary
Basilea Pharmaceutica AG
According to Wall Street analysts, the average 1-year price target for BSLN is 100.3 CHF with a low forecast of 70.7 CHF and a high forecast of 126 CHF.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BSLN's stock price target?
Price Target
100.3
CHF
According to Wall Street analysts, the average 1-year price target for BSLN is 100.3 CHF with a low forecast of 70.7 CHF and a high forecast of 126 CHF.
What is the Revenue forecast for Basilea Pharmaceutica AG?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 5 years is 2%.
What is the Gross Profit forecast for Basilea Pharmaceutica AG?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 5 years is 2%.
What is the Operating Income forecast for Basilea Pharmaceutica AG?
Projected CAGR
13%
The compound annual growth rate for Operating Income over the next 5 years is 13%.
What is the Pre-Tax Income forecast for Basilea Pharmaceutica AG?
Projected CAGR
36%
The compound annual growth rate for Pre-Tax Income over the next 2 years is 36%.
What is the Net Income forecast for Basilea Pharmaceutica AG?
Projected CAGR
17%
The compound annual growth rate for Net Income over the next 5 years is 17%.
